Dayanand Medical College is a tertiary care teaching hospital in Ludhiana in North India.

During the past decade, Dayanand Medical College & Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 9 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dayanand Medical College & Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Dayanand Medical College and Hospital" with 4 trials sponsored, "Galapagos NV" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Pharmazz, Inc." with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dayanand Medical College & Hospital" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Dayanand Medical College & Hospital" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (4 trials), "Cerebral Ischemia" (2 trials), "Chronic Hepatitis C" (2 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "Dayanand Medical College & Hospital" in a lesser frequency.

Most popular intervention types in "Dayanand Medical College & Hospital" are "Drug" (36 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Filgotinib" (5 trials), "Mirikizumab" (3 trials), "Etrolizumab" (2 trials) and "Normal Saline along with standard treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dayanand Medical College & Hospital" are 38 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Dayanand Medical College & Hospital". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Dayanand Medical College & Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dayanand Medical College & Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Dayanand Medical College & Hospital has several departments that took part in Clinical trials: "Department of Gastroenterology, D.M.C. and Hospital" - 3 trials